We confirmed the role of MACC1 in modulating ABCB1 expression in two CRC cell panels with differential MACC1 expression levels, and found corresponding de- and re-sensitization to doxorubicin treatment upon ectopic expression or knocking-out of MACC1, respectively. Here, ABCB1 is linked to colorectal carcinoma.